POLG and Hypoglycemia: The patient also had hypoglycemia during the episode, which has been associated with POLG1-related liver failure in Alpers patients with impaired mitochondrial respiratory chain activity [25], but it is also a common adverse effect of 6-MP treatment and high MeMP levels [4].